Public Profile

Noramco

Noramco, officially known as Noramco, Inc., is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2000, the company has established itself as a key provider of active pharmaceutical ingredients (APIs) and advanced drug delivery systems, primarily serving the global market. With operational facilities in the US and significant reach in Europe and Asia, Noramco is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of controlled substances and non-controlled APIs, distinguished by their rigorous compliance with regulatory standards. Noramco's strategic focus on research and development has led to notable achievements, positioning it as a trusted partner for pharmaceutical companies worldwide. With a strong market presence, Noramco continues to drive advancements in drug formulation and manufacturing, contributing to the evolving landscape of healthcare solutions.

DitchCarbon Score

How does Noramco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Noramco's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Noramco's reported carbon emissions

Noramco, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is unclear how their emissions profile looks in terms of Scope 1, 2, or 3 emissions. However, the absence of documented reduction initiatives or commitments suggests that Noramco may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for Noramco to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Noramco's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Noramco is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Noramco is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Par Pharmaceutical

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Endo Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Forest Laboratories, LLC

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Allergan

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Perrigo

IE
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers